Otonexus
CEO: Caitlin Cameron
OtoNexus Medical Technologies’ state-of-the-art advanced ultrasound otoscope analyzes the presence and type of effusion so that primary care pediatricians can instantly and accurately assess middle ear infections (otitis media). This type of information has never been available before without an invasive procedure.
Clinical studies show diagnostic error rates averaging 50 percent, particularly in the vital key differentiation of whether or not to prescribe an antibiotic.
With OtoNexus, clinicians will have a tool to determine the smart use of antibiotics. Definitive, objective diagnostic data identifying both the presence and the type of infection will lead to improved patient outcomes, better and faster treatment, reduced antibiotic usage, and significantly reduced healthcare costs.